The Indianapolis-based drugmaker sees orforglipron as a potential global breakthrough treatment for weight loss and other ...

Adding an SGLT2 inhibitor to finerenone in CKD and type 2 diabetes yields “remarkable” albuminuria reductions that may, if ...

Assembly Bill 555 would prohibit private insurance companies from charging people more than $35 for a 30-day supply of a ...

Twice as many Americans now face the increased risk of death that comes from having both high blood pressure and type 2 diabetes ... into a human patient last month and recorded neural activity ...

For November’s American Diabetes Month, here is important information to consider. Diabetes in children: While type 1 diabetes was historically known as juvenile diabetes, that term is no longer ...

“Prediabetes essentially means that your hemoglobin A1c, a measure of your three-month glucose values ... of primary care and quality at the American Diabetes Association.

Obesity specialists say first-generation anti-obesity medications often get a ‘bad wrap,’ but these drugs can be effective ...

The Centers for Disease Control and Prevention says children without underlying health conditions "may receive" a COVID-19 ...

Sen. Mike Rounds discussed U.S. strategies to combat China's intellectual property theft and AI's role in maintaining ...

GLP-1 drugs like Ozempic show widespread promise beyond weight loss/diabetes, but cost and supply limit broader adoption.

Ever since the pharmaceutical company Novo Nordisk realized that GLP-1 drugs were useful for more than diabetes, doctors and ...

Eli Lilly and Company thrives on its groundbreaking weight-loss drug tirzepatide. Learn why we could see a $50B market and ...